Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers

(MedPage Today) — Nivolumab (Opdivo) plus ipilimumab (Yervoy) showed significant activity in patients with advanced gynecologic clear cell carcinomas, according to results from a phase II nonrandomized trial.
Among 26 evaluable patients with…

Source link : https://www.medpagetoday.com/hematologyoncology/ovariancancer/116371

Author :

Publish date : 2025-07-03 15:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers

Sunvozertinib Wins Approval for EGFR-Mutated NSCLC

Brain Changes Linked to Dementia Found in Ex-Rugby Players

Related Posts

The illegal cigarettes trade in the UK signals a deeper problem

House Approves Trump’s Sweeping Tax Bill

3D printing could enable a safer long-term therapy for type 1 diabetes

Quantum computers are surprisingly random – but that’s a good thing

States Sue After Trump Admin Releases Private Medicaid Data to Deportation Officials

Supreme Court’s Medina Ruling Is a Blow to Medicaid Patients

The illegal cigarettes trade in the UK signals a deeper problem

House Approves Trump’s Sweeping Tax Bill

3D printing could enable a safer long-term therapy for type 1 diabetes

Quantum computers are surprisingly random – but that’s a good thing

States Sue After Trump Admin Releases Private Medicaid Data to Deportation Officials

Supreme Court’s Medina Ruling Is a Blow to Medicaid Patients

Pandemic Surge in IBS, Chronic Idiopathic Constipation

Seven ways the government’s plan could change the NHS

Categories

Archives